De Vincentis Sara, Evangelisti Selene, Rossi Barbara, Decaroli Maria Chiara, Locaso Michela, Ansaloni Anna, Ferrara Francesca, Corradini Elena, Pietrangelo Antonello, Rochira Vincenzo
Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria Policlinico di Modena, Ospedale Civile di Baggiovara, Modena, Italy.
Endocrine. 2025 Mar;87(3):1257-1266. doi: 10.1007/s12020-024-04124-4. Epub 2024 Dec 4.
To explore the prevalence of hypoparathyroidism (HPT), overt and subclinical, in a cohort of adults with Iron Overload Diseases (IOD). Secondary aim was to test the calcium (Ca)-to-phosphorus (P) ratio performance in identifying HPT.
Single-center, prospective, case-control study. Sixty-five IOD, 40 with thalassemia major/intermedia (TMI) and 25 with hemochromatosis (HC), and 76 age-matched controls were included. Main outcomes (serum Ca, P, Ca/P ratio, intact parathyroid hormone (PTH), albumin) defined overt and subclinical HPT.
Albumin-adjusted Ca was lower (p = 0.004) and P higher (p = 0.002) comparing IOD to controls. Ca/P ratio was lower in IOD than controls (p < 0.001); PTH did not change. P was higher and Ca/P lower comparing TMI to HC and controls (p < 0.001); Ca did not change. A total of 28/65 IOD (43%) had HPT (9.2% overt, 33.8% subclinical) whose prevalence was higher in TMI than HC (p < 0.001). Ca/P ratio <2.32 had sensitivity 71.4% and specificity 83.9% in detecting overt/subclinical HPT. IOD with Ca/P ratio <2.32 (1.78 in SI) had an almost 12-fold increased likelihood to be affected by HPT (OR 12.92 [3.90-42.82]; p < 0.001). Ca/P (p = 0.002) was the only independent risk factor for HPT at multivariate analysis.
HPT, especially non-classical subclinical HPT, is common in adult IOD with higher prevalence in TMI than HC. Ca/P ratio <2.32 is accurate to screen for overt/subclinical HPT and should be periodically evaluated in IOD to early detect an unbalanced mineral metabolism, and to monitor a possible evolution from subclinical to overt HPT.
探讨铁过载疾病(IOD)成年人群中显性和亚临床甲状旁腺功能减退症(HPT)的患病率。次要目的是检验钙(Ca)磷(P)比值在识别HPT中的性能。
单中心、前瞻性病例对照研究。纳入65例IOD患者,其中40例重型/中间型地中海贫血(TMI)患者和25例血色素沉着症(HC)患者,以及76例年龄匹配的对照者。主要观察指标(血清Ca、P、Ca/P比值、完整甲状旁腺激素(PTH)、白蛋白)用于定义显性和亚临床HPT。
与对照组相比,IOD患者经白蛋白校正的Ca较低(p = 0.004),P较高(p = 0.002)。IOD患者的Ca/P比值低于对照组(p < 0.001);PTH无变化。与HC及对照组相比,TMI患者的P较高,Ca/P较低(p < 0.001);Ca无变化。65例IOD患者中共有28例(43%)患有HPT(9.2%为显性,33.8%为亚临床),其患病率在TMI患者中高于HC患者(p < 0.001)。Ca/P比值<2.32在检测显性/亚临床HPT时的敏感性为71.4%,特异性为83.9%。Ca/P比值<2.32(国际单位制中为1.78)的IOD患者患HPT的可能性增加近12倍(比值比12.92 [3.90 - 42.82];p < 0.001)。在多变量分析中,Ca/P(p = 0.002)是HPT的唯一独立危险因素。
HPT,尤其是非经典亚临床HPT,在成年IOD患者中常见,在TMI患者中的患病率高于HC患者。Ca/P比值<2.32可准确筛查显性/亚临床HPT,应在IOD患者中定期评估,以早期发现矿物质代谢失衡,并监测从亚临床HPT向显性HPT的可能进展。